Ritonavir Completed Phase 4 Trials for Glucose Metabolism Disorders / Human Immunodeficiency Virus (HIV) Infections / Lipodystrophies / Dyslipidemia / Cardiovascular Disease (CVD) / Metabolic Diseases Basic Science
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Basic Science | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00192621 | Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects |